Tuesday, March 19, 2024
Advertisement
Updated on: September 16, 2021 13:10 IST

COVID-19 antibodies persist, reduce reinfection risk for up to six months: Study

A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.

Latest Videos

Advertisement
Advertisement
Advertisement
Advertisement